Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products: letter to the editor.
Pfizer Biotech; Dublin, Ireland.
Brian
B
Hassett
Scott
S
McMillen
Brian
B
Fitzpatrick
D000818:Animals; D059451:Biosimilar Pharmaceuticals / Q000494:pharmacology*; D005347:Fibroblasts / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology*; D011993:Recombinant Fusion Proteins / Q000378:metabolism*
D059451:Biosimilar Pharmaceuticals; D007074:Immunoglobulin G; D011993:Recombinant Fusion Proteins